LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC (EIN 455312680) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

DR OZLEM GOKER-ALPAN

Phone

7032616220

Tax Period

2023-01-01 to 2023-12-31

LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC, founded in 2012, is a community nonprofit in the Medical Research sector that reported $1.9M in total revenue in fiscal year 2020. Expenses of $2.2M exceeded revenue, resulting in a 14% operating deficit.

Mission

RESEARCH AND UNRAVEL DISEASE CAUSING MECHANISMS AND EXPLORE NEW BIOMARKERS AND TREATMENT OPTIONS.

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $491,100

Program Service Revenue $2,860,290

Investment Income $0

Other Revenue $0

TOTAL REVENUE $3,351,390

Expense Breakdown

Grants Paid $5,000

Salaries & Benefits $1,694,420

Fundraising Expenses $0

Program Expenses $3,332,840

Other Expenses $1,977,294

TOTAL EXPENSES $3,676,714

Year-over-Year Comparison

	2023	2022	Change
Revenue	$3,351,390	$3,020,151	+0.1%
Expenses	$3,676,714	$2,474,219	+0.5%
Net Income	$-325,324	$545,932	-1.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$446,512

Total Directors

$551,941

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DR OZLEM GOKER-ALPAN	PRESIDENT / FOUNDER	16.00	Officer Director	$289,151	$7,804	$296,955
LAUREN NOLL	DIRECTOR / MANAGER	8.00	Director	$101,862	$3,567	$105,429
BOBBY SANDHU	SECRETARY / LPN	8.00	Officer Director	$73,800	$0	$73,800
UYENSA BEESE	TREASURER / OPERATIONS DIRECTOR	24.00	Officer Director	$70,458	$5,299	$75,757
MARGARITA IVANOVA	DIR. OF TRANSLATIONAL RESEARCH	40.00	Highest	$112,241	$0	$112,241
LIA H VAN	NURSE PRACTITIONER	40.00	Highest	$105,715	$0	$105,715

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$3,351,390	$3,676,714	$1,851,613	$-325,324
2022	$3,020,151	$2,474,219	$2,144,032	$545,932
2021	$2,664,551	$2,093,309	$1,635,612	$571,242
2020	$1,934,480	$2,201,912	$834,123	$-267,432

LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC